CRISPR-Based Approaches for Efficient and Accurate Detection of SARS-CoV-2

Lab Med. 2021 Mar 15;52(2):116-121. doi: 10.1093/labmed/lmaa101.

Abstract

An outbreak of COVID-19, caused by infection with SARS-CoV-2 in Wuhan, China in December 2019, spread throughout the country and around the world, quickly. The primary detection technique for SARS-CoV-2, the reverse-transcription polymerase chain reaction (RT-PCR)-based approach, requires expensive reagents and equipment and skilled personnel. In addition, for SARS-CoV-2 detection, specimens are usually shipped to a designated laboratory for testing, which may extend the diagnosis and treatment time of patients with COVID-19. The latest research shows that clustered regularly interspaced short palindromic repeats (CRISPR)-based approaches can quickly provide visual, rapid, ultrasensitive, and specific detection of SARS-CoV-2 at isothermal conditions. Therefore, CRISPR-based approaches are expected to be developed as attractive alternatives to conventional RT-PCR methods for the efficient and accurate detection of SARS-CoV-2. Recent advances in the field of CRISPR-based biosensing technologies for SARS-CoV-2 detection and insights into their potential use in many applications are reviewed in this article.

Keywords: 2019-nCoV; COVID-19; CRISPR; SARS-CoV-2; diagnosis.

Publication types

  • Review

MeSH terms

  • COVID-19 Nucleic Acid Testing*
  • Clustered Regularly Interspaced Short Palindromic Repeats*
  • Humans
  • SARS-CoV-2 / isolation & purification*